Reconsidering the role of PMRT in low to intermediate risk breast cancer: Applying results from previous standards of treatment in the current multimodal practice | Synapse
March 3, 2026
Reconsidering the role of PMRT in low to intermediate risk breast cancer: Applying results from previous standards of treatment in the current multimodal practice
Key Points
This analysis reconsiders the role of PMRT based on previous standards, suggesting updated treatment approaches.
Key findings indicate that PMRT may improve outcomes in specific breast cancer risk categories, with patient selection crucial.
Assessment of treatment efficacy involved reviewing historical data on breast cancer management and outcomes across varying risks.
The implications of this study may lead to refined guidelines for PMRT application in multimodal treatment, enhancing patient care.